Mark S. Ordan
Chief Executive Officer at Pediatrix Medical Group Inc.
Sits on 2 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Pediatrix Medical Group Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
The Carlyle Group Inc. June 3, 202697.0%
-
Pediatrix Medical Group Inc. May 7, 202696.9%
-
Pediatrix Medical Group Inc. May 8, 202597.2%
-
Pediatrix Medical Group Inc. May 9, 202497.3%
-
The Carlyle Group Inc. May 30, 202398.1%
-
Pediatrix Medical Group Inc. May 11, 202397.5%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 2, 2026 | Pediatrix Medical Group Inc. | Sold back to the company | −97,174 | — | — |
| Jun 2, 2026 | Pediatrix Medical Group Inc. | Grant or award | +97,174 | — | — |
| Jun 1, 2026 | Pediatrix Medical Group Inc. | Grant or award | +127,198 | — | — |
| Jun 1, 2026 | Pediatrix Medical Group Inc. | Shares withheld for tax | −19,119 | $21.54 | $411,823 |
| May 1, 2026 | The Carlyle Group Inc. | Grant or award | +4,450 | — | — |
| May 1, 2026 | The Carlyle Group Inc. | Grant or award | +4,450 | $49.44 | $220,008 |
| Dec 15, 2025 | Pediatrix Medical Group Inc. | Open-market sale | −23,000 | $22.41 | $515,430 |
| Jun 1, 2025 | Pediatrix Medical Group Inc. | Grant or award | +194,347 | — | — |
| May 9, 2025 | Pediatrix Medical Group Inc. | Shares withheld for tax | −7,225 | $14.44 | $104,329 |
| May 1, 2025 | The Carlyle Group Inc. | Grant or award | +5,235 | — | — |
| Nov 13, 2024 | Pediatrix Medical Group Inc. | Open-market sale | −27,600 | $15.35 | $423,660 |
| May 9, 2024 | Pediatrix Medical Group Inc. | Grant or award | +18,360 | — | — |
| May 1, 2024 | The Carlyle Group Inc. | Grant or award | +5,004 | — | — |
| May 25, 2023 | Pediatrix Medical Group Inc. | Open-market sale | −33,000 | $13.26 | $437,580 |
| May 11, 2023 | Pediatrix Medical Group Inc. | Grant or award | +9,463 | — | — |
Questions about Mark S. Ordan
What boards is Mark S. Ordan on?
Mark S. Ordan sits on the boards of Pediatrix Medical Group Inc. and The Carlyle Group Inc.
What company is Mark S. Ordan the CEO of?
Mark S. Ordan is Chief Executive Officer of Pediatrix Medical Group Inc.
How long has Mark S. Ordan served on boards?
Our records show at least 7 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.